Stock Comparison

NUVB vs VRTX

Nuvation Bio Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

NUVB

Nuvation Bio Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$2.14B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

—

25.7

Price/Sales

12.6

9.9

Price/Book

8.5

6.1

EV/EBITDA

2.1

23.2

Dividend Yield

—

Profitability

Net Margin

-102.06%

35.40%

Operating Margin

-104.99%

38.97%

Return on Equity

-47.80%

23.50%

Return on Assets

-12.40%

11.90%

Growth (YoY)

Revenue Growth

556.00%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

1.5

0.3

52-Week High

$9.54

$529.65

52-Week Low

$2.69

$376.62

Analyst Target

$12.89

$559.28

Compare NUVB and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.